Journal of Cachexia Sarcopenia and Muscle-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2025-01-12 124d4ad8m98暂无昵称来自广东省

不是全都送审吗，怎么一个月就dip了呜呜呜

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2025-01-12 ms5000002977722138 来自上海

是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。
平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2024-11-26 ms2000001788822131 来自上海

审稿速度:3.0 | 投稿命中率:50.0
经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。
审稿周期通常较长，平均需要16周左右的时间。
在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助）
要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。
大家还了解哪些可以继续补充

40 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2024-11-20 ms3000001983661864 来自北京

审稿速度:24.0 | 投稿命中率:25.0
偏重的研究方向：肌萎缩
经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月

33 34

展开34条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2025-01-03 ms1000002013946887 来自浙江省

20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关

9 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2024-11-23 ms4000000384958423 来自广东省

一直 submitted 什么情况 11.15投的没变过

14 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2024-08-05 1467de12m97暂无昵称来自江苏省

偏重的研究方向：低肌肉质量;临床
经验分享：记录一下，8月2号投的，现在是 submit to journal

61 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2024-11-30 ms2000000373480608 来自上海

投稿命中率:25.0
偏重的研究方向：老年医学;分子机理
经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……

11 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2024-11-29 ms6000000691767799 来自新加坡

审稿速度:12.0 | 投稿命中率:5.0
经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗

14 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247713, encodeId=9647224e71375, content=不是全都送审吗，怎么一个月就dip了呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Sun Jan 12 17:27:32 CST 2025, time=2025-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247756, encodeId=0582224e7566e, content=是一本同行评审的期刊，专注于与恶病质、肌肉减少症以及身体成分变化相关的研究。主要收录与恶病质、肌肉减少症相关的原创研究、综述文章、临床材料等。 平均审稿周期在16周左右，该期刊为季刊，每年出版四期。最后说该期刊需要支付版面费，可以接受活想投稿，一定要仔细阅读期刊的投稿manbetx手机版和要求后再行动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 21:10:41 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡)]

2024-11-26 ms6000000691767799 来自新加坡

审稿速度:3.0
偏重的研究方向：消化道肿瘤
经验分享：可怕这个杂志是所有文章都送审吗

15 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务